Bandla Harikrishna, Dasgupta Debanjali, Mauer Amy S, Nozickova Barbora, Kumar Swarup, Hirsova Petra, Graham Rondell P, Malhi Harmeet
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
Hepatol Res. 2018 May;48(6):479-494. doi: 10.1111/hepr.13052. Epub 2018 Feb 9.
Activation of PKR-like endoplasmic reticulum kinase (PERK), an endoplasmic reticulum stress sensor, is a feature of non-alcoholic steatohepatitis (NASH), yet regulators of PERK signaling remain undefined in this context. The protein p58 regulates PERK; however, its role in NASH has not been examined. The aim of this study was to assess the in vivo role of p58 in the pathogenesis of dietary NASH.
Parameters of hepatocyte cell death, liver injury, inflammation, fibrosis, indirect calorimetry and PERK activation were assessed in p58 knockout (p58 ) mice and their wild-type littermate controls. All animals were fed a diet enriched in fat, fructose, and cholesterol (FFC) for 20 weeks.
Activation of PERK was attenuated in FFC-fed p58 mice. Accordingly, FFC-fed p58 mice showed a reduction in hepatocyte apoptosis and death receptor expression, with a significant reduction in serum alanine transaminase values. Correspondingly, macrophage accumulation and fibrosis were significantly lower in FFC-fed p58 mice.
We have shown that, in an in vivo dietary NASH model, p58 mediates hepatocyte apoptosis and liver injury, likely through PERK phosphorylation. In the absence of p58 , PERK phosphorylation and NASH are attenuated. Inhibition of hepatic p58 could be a future target for NASH therapy.
蛋白激酶R样内质网激酶(PERK)作为一种内质网应激感受器,其激活是非酒精性脂肪性肝炎(NASH)的一个特征,但在此背景下PERK信号通路的调节因子仍不明确。蛋白p58可调节PERK;然而,其在NASH中的作用尚未得到研究。本研究的目的是评估p58在饮食诱导的NASH发病机制中的体内作用。
在p58基因敲除(p58−/−)小鼠及其野生型同窝对照小鼠中评估肝细胞死亡、肝损伤、炎症、纤维化、间接测热法和PERK激活等参数。所有动物均喂食富含脂肪、果糖和胆固醇(FFC)的饲料20周。
喂食FFC的p58−/−小鼠中PERK的激活减弱。相应地,喂食FFC的p58−/−小鼠的肝细胞凋亡和死亡受体表达减少,血清丙氨酸转氨酶值显著降低。相应地,喂食FFC的p58−/−小鼠中的巨噬细胞聚集和纤维化显著降低。
我们已经表明,在体内饮食性NASH模型中,p58可能通过PERK磷酸化介导肝细胞凋亡和肝损伤。在缺乏p58的情况下,PERK磷酸化和NASH减弱。抑制肝脏p58可能是未来NASH治疗的一个靶点。